Hepatic arterial chemoembolization using drug-eluting beads in gastrointestinal neuroendocrine tumor metastatic to the liver

CardioVascular and Interventional Radiology

Volumn 34, Issue 3, 2011, Pages 566-572

  Gaur, Shantanu K ^a   Friese, Jeremy L ^a   Sadow, Cheryl A ^a   Ayyagari, Rajasekhara ^a   Binkert, Christoph A ^b   Schenker, Matthew P ^a   Kulke, Matthew ^c   Baum, Richard ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Carcinoid; Chemoembolization; Embolization; Liver; Neuroendocrine tumor

Indexed keywords

DOXORUBICIN; DRUG CARRIER; DRUG ELUTING BEAD; MICROSPHERE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BILE DUCT INJURY; CANCER CLASSIFICATION; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATIC ARTERY; HUMAN; LIVER METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT RESPONSE; UPPER ABDOMINAL PAIN;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; CHEMOEMBOLIZATION, THERAPEUTIC; DISEASE PROGRESSION; DOXORUBICIN; FEMALE; GASTROINTESTINAL NEOPLASMS; HEPATIC ARTERY; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79959623716     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-011-0122-1     Document Type: Article

References (42)

1. Brown KT, Koh BY, Brody LA et al (1999) Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms. J Vasc Interv Radiol 10(4):397-403 (Pubitemid 29190243)
2. Brown DB, Gould JE, Gervais DA et al (2007) Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol 18(12):1469-1478 (Pubitemid 350151879)
3. Caplin ME, Buscombe JR, Hilson AJ, Jones AL, Watkinson AF, Burroughs AK (1998) Carcinoid tumour. Lancet 352(9130): 799-805 (Pubitemid 128717532)
4. Clouse ME, Perry L, Stuart K, Stokes KR (1994) Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Digestion 55:92-97
5. de Baere T, Deschamps F, Teriitheau C et al (2008) Transarterial chemoembolization of liver metastases from well-differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results. J Vasc Interv Radiol 19(6): 855-861
6. Demeure MJ, Thompson NW, Hanto DW, Nagorney DM, Yao (2001) Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery 130(4):682-685 (Discussion)
7. Diaco DS, Hajarizadeh H, Mueller CR, Fletcher WS, Pommier RF, Woltering EA (1995) Treatment of metastatic carcinoidtumors using multimodality therapy of octreotide acetate intraarterial chemotherapy, and hepatic arterial chemoembolization. Am J Surg 169(5):523-528
8. Diamandidou E, Ajani JA, Yang DJ et al (1998) Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors. AJR Am J Roentgenol 170(2):339-344 (Pubitemid 28083835)
9. Dominguez S, Denys A, Menu Y, Ruszniewski P (1999) Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumours. Ital J Gastroenterol Hepatol 31: S213-S215 (Pubitemid 29527898)
10. Dominguez S, Denys A, Madeira I et al (2000) Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours. Eur J Gastroenterol Hepatol 12(2):151-157 (Pubitemid 30166679)
11. Drougas JG, Anthony LB, Blair TK et al (1998) Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors. Am J Surg 175(5):408-412 (Pubitemid 28213456)
12. Eriksson BK, Larsson EG, Skogseid BM, Lofberg AM, Lorelius LE, Oberg KE (1998) Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors. Cancer 83(11): 2293-2301 (Pubitemid 28533498)
13. Fiorentini G, Aliberti C, Turrisi G et al (2007) Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study. In Vivo 21(6):1085-1091
14. Gates J, Hartnell GG, Stuart KE, Clouse ME (1999) Chemoembolization of hepatic neoplasms: safety, complications, and when to worry. Radiographics 19(2):399-414
15. Gupta S, Yao JC, Ahrar K et al (2003) Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the MD Anderson experience. Cancer J 9(4):261-267
16. Hajarizadeh H, Ivancev K, Mueller CR, Fletcher WS, Woltering EA (1992) Effective palliative treatment of metastatic carcinoidtumors with intraarterial chemotherapy chemoembolization combined with octreotide acetate. Am J Surg 163(5):479-483
17. Ho AS, Picus J, Darcy MD et al (2007) Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors. AJR Am J Roentgenol 188(5):1201-1207 (Pubitemid 46668497)
18. Kadivar F, Soulen MC (2010) Enhancing ablation: synergies with regional and systemic therapies. J Vasc Interv Radiol 21(8 Suppl): S251-S256
19. Kim YH, Ajani JA, Carrasco CH et al (1999) Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma. Cancer Invest 17(7): 474-478 (Pubitemid 29458119)
20. Kulke M (2005) Advances in the treatment of neuroendocrine tumors. Curr Treat Options Oncol 6(5):397-409
21. Kulke MH, Mayer RJ (1999) Carcinoid tumors. N Engl J Med 340(11):858-868 (Pubitemid 29142631)
22. Lammer J, Malagari K, Vogl T et al (2009) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33(1):41-52
23. Lewis AL, Taylor RR, Hall B, Gonzalez MV, Willis SL, Stratford PW (2006) Pharmacokinetic and safety study of doxorubicineluting beads in a porcine model of hepatic arterial embolization. J Vasc Interv Radiol 17(8):1335-1343 (Pubitemid 44259017)
24. Loewe C, Schindl M, Cejna M, Niederle B, Lammer J, Thurnher S (2003) Permanent transarterial embolization of neuroendocrine metastases of the liver using cyanoacrylate and lipiodol: assessment of mid- and long-term results. AJR Am J Roentgenol 180(5):1379-1384 (Pubitemid 36504631)
25. Marlink RG, Lokich JJ, Robins JR, Clouse ME (1990) Hepatic arterial embolization for metastatic hormone-secreting tumors: technique, effectiveness, and complications. Cancer 65(10):2227-2232 (Pubitemid 20164827)
26. Maton PN (1988) The carcinoid syndrome. JAMA 260(11):1602-1605
27. Modlin IM, Sandor A (1997) An analysis of 8305 cases of carcinoid tumors. Cancer 79(4):813-829 (Pubitemid 27076348)
28. Moertel CG, Lefkopoulo M, Lipsitz S, Hahn RG, Klaassen D (1992) Streptozocin doxorubicin, streptozocin fluorouracil, or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med 326(8):519-523
29. Musunuru S, Chen H, Rajpal S et al (2006) Metastatic neuroendocrine hepatic tumors: resection improves survival. Arch Surg 141(10):1000-1004 (Pubitemid 44583257)
30. Ollivier S, Fonck M, Becouarn Y, Brunet R (1998) Dacarbazine, fluorouracil, and leucovorin in patients with advanced neuroendocrine tumors: a phase II trial. Am J Clin Oncol Cancer Clinical Trials 21(3):237-240 (Pubitemid 28280131)
31. Osborne DA, Zervos EE, Strosberg J et al (2006) Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors. Ann Surg Oncol 13(4):572-581
32. Rhee TK, Lewandowski RJ, Liu DM et al (2008) Y-90 radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience. Ann Surg 247(6):1029-1035 (Pubitemid 351770424)
33. Rinke A, Muller HH, Schade-Brittinger C et al (2009) Placebocontrolled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol 27(28):4656-4663
34. Rougier P, Mitry E (2000) Chemotherapy in the treatment of neuroendocrine malignant tumors. Digestion 62:73-78 (Pubitemid 30665943)
35. Ruszniewski P, Malka D (2000) Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumors. Digestion 62:79-83 (Pubitemid 30665944)
36. Ruutiainen AT, Soulen MC, Tuite CM et al (2007) Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver. J Vasc Interv Radiol 18(7):847-855 (Pubitemid 46963614)
37. Schnirer II, Yao JC, Ajani JA (2003) Carcinoid: a comprehensive review. Acta Oncologica 42(7):672-692 (Pubitemid 37445288)
38. Therasse E, Breittmayer F, Roche A et al (1993) Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology 189(2):541-547 (Pubitemid 23321441)
39. van der Lely AJ, de Herder WW (2005) Carcinoid syndrome: diagnosis and medical management. Arq Bras Endocrinol Metabol 49(5):850-860
40. Varela M, Real MI, Burrel M et al (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46(3):474-481 (Pubitemid 46201723)
41. Venook AP (1999) Embolization and chemoembolization therapy for neuroendocrine tumors. Curr Opin Oncol 11(1):38-41
42. Yao JC, Hassan M, Phan A et al (2008) One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26(18):3063-3072